4.8 Article

Priority actions for the non-communicable disease crisis

Journal

LANCET
Volume 377, Issue 9775, Pages 1438-1447

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(11)60393-0

Keywords

-

Funding

  1. Wellcome Trust
  2. Family Health International
  3. 19 Inter-American Development Bank
  4. Bayer
  5. Allergan
  6. Syngis
  7. Servier
  8. 22 Photothera
  9. Boehringer-Ingelheim
  10. Pfizer
  11. Wiley
  12. Sanofi-Aventis
  13. Varian Medical Systems
  14. Roche
  15. Boehringer Ingelheim
  16. Novartis
  17. Slender
  18. 23 Merck
  19. Eli Lilly
  20. Heng Rui
  21. Irmet
  22. National Heart Forum

Ask authors/readers for more resources

The UN High-Level Meeting on Non-Communicable Diseases (NCDs) in September, 2011, is an unprecedented opportunity to create a sustained global movement against premature death and preventable morbidity and disability from NCDs, mainly heart disease, stroke, cancer, diabetes, and chronic respiratory disease. The increasing global crisis in NCDs is a barrier to development goals including poverty reduction, health equity, economic stability, and human security. The Lancet NCD Action Group and the NCD Alliance propose five overarching priority actions for the response to the crisis leadership, prevention, treatment, international cooperation, and monitoring and accountability and the delivery of five priority interventions tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous alcohol intake, and essential drugs and technologies. The priority interventions were chosen for their health effects, cost-effectiveness, low costs of implementation, and political and financial feasibility. The most urgent and immediate priority is tobacco control. We propose as a goal for 2040, a world essentially free from tobacco where less than 5% of people use tobacco. Implementation of the priority interventions, at an estimated global commitment of about US$9 billion per year, will bring enormous benefits to social and economic development and to the health sector. If widely adopted, these interventions will achieve the global goal of reducing NCD death rates by 2% per year, averting tens of millions of premature deaths in this decade.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available